European Neuroendocrine Tumor Society (<scp>ENETS</scp>) 2023 guidance paper for gastroduodenal neuroendocrine tumours (<scp>NETs) G1

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3

Published:2023-07-04 Issue:8 Volume:35 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Panzuto Francesco¹^ORCID,Ramage John²^ORCID,Pritchard D. Mark³^ORCID,van Velthuysen Marie‐Louise F.⁴^ORCID,Schrader Joerg⁵,Begum Nehara⁶,Sundin Anders⁷^ORCID,Falconi Massimo⁸,O'Toole Dermot⁹

Affiliation:

1. Department of Medical‐Surgical Sciences and Translational Medicine, Digestive Disease Unit Sant'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome Rome Italy

2. Department of Gastroenterology Hampshire Hospitals and ENETS Center, Kings Health Partners London London United Kingdom

3. Department of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool UK

4. Department of Pathology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands

5. Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

6. Department for General‐, Visceral‐, Thoracic‐ and Endocrine Surgery, Johannes‐Wesling‐Klinikum Minden University Hospital of the Ruhr‐University Bochum Bochum Germany

7. Department of Surgical Sciences, Radiology & Molecular Imaging Uppsala University Uppsala Sweden

8. Pancreas Translational and Clinical Research Center, Pancreatic Surgery Unit IRCCS San Raffaele Scientific Institute Milan Italy

9. National Centre for Neuroendocrine Tumours, ENETS Centre of Excellence, St. Vincent's University Hospital Dublin Ireland

Abstract

AbstractThe aim of the present guidance paper was to update the previous ENETS guidelines on well‐differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13306

Reference65 articles.

1. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

2. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H+K+ATPase alpha subunit

3. Gastric neuroendocrine tumours from long‐term proton pump inhibitor users are indolent tumours with good prognosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal management of foregut neuroendocrine neoplasms;Best Practice & Research Clinical Gastroenterology;2024-02

2. Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management;Frontiers in Medicine;2024-01-31

3. Endoscopic Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours: An Overview of Proposed Resection and Ablation Techniques;Cancers;2024-01-13

4. ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms;Annals of Surgical Oncology;2024-01-02

5. Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED);Digestive and Liver Disease;2024-01